| Ytd | -17.55% | |
| 1y | -10.29% |
| Open | 78.60 | Prev Close | 78.23 | Low | 78.65 | High | 80.28 | Mkt Cap | 101.38B |
| Vol | 6.11M | Avg Vol | 10.26M | EPS | 3.73 | P/E | 21.23 | Forward P/E | 12.37 |
| Beta | 0.60 | Short Ratio | 1.59 | Inst. Own | 89.64% | Dividend | 2.88 | Div Yield | 3.68 |
| Ex Div Date | 06-26 | Earning | 08-18 | 50-d Avg | 79.03 | 200-d Avg | 91.39 | 1yr Est | 97.77 |
Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change
On June 30, 2026, Medtronic PLC (MDT) shares fell 3.3% today, bringing the current price to $78.23.
Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside
Investors turn to dividend-yielding stocks in turbulent markets. Benzinga offers latest analyst rati
The Nasdaq 100 has tripled since 2020, but 10 mega-caps still trade below pre-Covid levels. Who'
During market turbulence, investors turn to dividend-yielding stocks. Benzinga offers latest analyst
Goldman Sachs analyst David Roman maintains Medtronic (NYSE:MDT) with a Neutral and lowers the pr
Bernstein analyst Lee Hambright maintains Medtronic (NYSE:MDT) with a Outperform and lowers the p
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerati
UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price tar
RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Outperform and maintains
Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and lowers t
Leerink Partners analyst Mike Kratky maintains Medtronic (NYSE:MDT) with a Outperform and lowers
Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price ta
Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the pr
Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target
Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardio
Medtronic (NYSE:MDT) reported quarterly earnings of $1.55 per share which beat the analyst consensus
General surgery indication including hernia repair — 510(k) clearance submittedEmbrace Gynecology In
ICE catheters provide real-time, high-resolution imaging of the heart during electrophysiology (EP)
Medtronic (NYSE:MDT) reported quarterly earnings of $1.50 per share which missed the analyst consens
June 3, 2026: Polymarket traders tilt bearish on the S&P 500 despite record highs, AI optimism a
Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Rec
U.S. stocks closed higher on Tues. Dow Jones up 0.45%. CNN Fear & Greed index shows positive mar
The S&P 500 Index is at crossroads as it sits at a record high. Here are the top three catalysts
Major M&A deals this week include Cohere acquiring Reliant AI and Authentic Brands buys denim br
The acquisition continues Medtronic's momentum in driving strategic deals that further build out
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"),
Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that
Payment fulfills previously disclosed funding commitment of $20 million and supports planned complet
The health care sector has oversold stocks with RSI below 30, presenting an opportunity for traders
Together, the two BDDs for AVIM Therapy cover indications that encompass both the broader population
Investors turn to dividend-yielding stocks during market turbulence. Benzinga's database offers
HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the S
UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price tar
Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and lowers
Investors turn to high-yielding dividend stocks in turbulent markets. Benzinga readers can check ana
Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the pr
Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and lower
Citigroup analyst Joanne Wuensch maintains Medtronic (NYSE:MDT) with a Buy and lowers the price t
Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and lower
Argus Research analyst David Toung maintains Medtronic (NYSE:MDT) with a Buy and lowers the price
Barclays analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Overweight and raises the pric
Piper Sandler analyst Matt O'Brien maintains Medtronic (NYSE:MDT) with a Neutral and lowers t
Tempus AI says ALERT trial shows higher valve procedures and faster care, while analysts keep a Buy
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising c
ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR
GlucoTrack targets a Q2 2026 FDA IDE filing for CGM, backed by clinical data, manufacturing strategy
Built for high reliability, world's only lumenless defibrillation lead approved for placement in